日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.

利用亚克隆反应异质性来定义癌症类器官的治疗敏感性

Kratz Jeremy D, Rehman Shujah, Johnson Katherine A, Gillette Amani A, Sunil Aishwarya, Favreau Peter F, Pasch Cheri A, Miller Devon, Zarling Lucas C, Yeung Austin H, Clipson Linda, Anderson Samantha J, Steimle Alyssa K, Sprackling Carley M, Lemmon Kayla K, Abbott Daniel E, Burkard Mark E, Bassetti Michael F, Eickhoff Jens C, Foley Eugene F, Heise Charles P, Kimple Randall J, Lawson Elise H, LoConte Noelle K, Lubner Sam J, Mulkerin Daniel L, Matkowskyj Kristina A, Sanger Cristina B, Uboha Nataliya V, Mcilwain Sean J, Ong Irene M, Carchman Evie H, Skala Melissa C, Deming Dustin A

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

可测量的残留病灶状态对接受异基因造血干细胞移植的急性髓系白血病成人患者复发和生存预测准确性的贡献

Rodríguez-Arbolí, Eduardo; Othus, Megan; Orvain, Corentin; Zarling, Lucas C; Sandmaier, Brenda M; Milano, Filippo; Schoch, Gary; Davis, Chris; Deeg, H Joachim; Appelbaum, Frederick R; Storb, Rainer; Walter, Roland B

Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia

剂量调整后的 EPOCH 方案作为高危急性淋巴细胞白血病成人患者初始治疗的 II 期研究

Cassaday, Ryan D; Zarling, Lucas C; Garcia, Kelsey-Leigh A; Sala-Torra, Olga; Stevenson, Philip A; Martino, Christen H; Liu, Yajuan J; Fang, Min; Percival, Mary-Elizabeth M; Halpern, Anna B; Becker, Pamela S; Oehler, Vivian G; Shustov, Andrei R; Cooper, Jason P; Orozco, Johnnie J; Hendrie, Paul C; Walter, Roland B; Radich, Jerald P; Soma, Lorinda A; Estey, Elihu H